share_log

晶泰控股-P：董事會召開日期

XTALPI-P: DATE OF BOARD MEETING

HKEX ·  Mar 18 08:39

Summary by Moomoo AI

晶泰控股有限公司將於2025年3月28日（星期五）召開董事會會議，主要議程包括審議及通過截至2024年12月31日止的全年業績，並考慮建議派發末期股息事宜。會議將由董事會主席兼執行董事溫書豪博士主持，出席會議的董事會成員包括執行董事馬健博士、賴力鵬博士及蔣一得博士，以及獨立非執行董事羅卓堅先生、陳穎琪女士及周明笙先生。
晶泰控股有限公司將於2025年3月28日（星期五）召開董事會會議，主要議程包括審議及通過截至2024年12月31日止的全年業績，並考慮建議派發末期股息事宜。會議將由董事會主席兼執行董事溫書豪博士主持，出席會議的董事會成員包括執行董事馬健博士、賴力鵬博士及蔣一得博士，以及獨立非執行董事羅卓堅先生、陳穎琪女士及周明笙先生。
Crystal King Holdings Limited will hold a Board of Directors meeting on March 28, 2025 (Friday), the main agenda includes reviewing and approving the full year performance for the year ending December 31, 2024, and considering the proposal for the payment of a final dividend. The meeting will be chaired by Dr. Wen Shuhao, Chairman of the Board and Executive Director, and the Board members attending the meeting include Executive Director Dr. Ma Jian, Dr. Lai Lipeng, and Dr. Jiang Yide, as well as Independent Non-Executive Directors Mr. Luo Zhuoqian, Ms. Chen Yingqi, and Mr. Zhou Mingsheng.
Crystal King Holdings Limited will hold a Board of Directors meeting on March 28, 2025 (Friday), the main agenda includes reviewing and approving the full year performance for the year ending December 31, 2024, and considering the proposal for the payment of a final dividend. The meeting will be chaired by Dr. Wen Shuhao, Chairman of the Board and Executive Director, and the Board members attending the meeting include Executive Director Dr. Ma Jian, Dr. Lai Lipeng, and Dr. Jiang Yide, as well as Independent Non-Executive Directors Mr. Luo Zhuoqian, Ms. Chen Yingqi, and Mr. Zhou Mingsheng.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 285

Recommended

Related Stocks Related Stocks
Symbol Mini Chart Price
LEPU BIO-B
02157
3.810
MEGA GENOMICS
06667
7.250
MABPHARM-B
02181
0.640
RECBIO-B
02179
8.300
ZAI LAB
09688
30.850
Log In for the Full List
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
Fed rate cut expectations for 2025 intensify. What’s your market outlook?
43%
57%
Bullish
Bearlish
1578 votes
FOMC Press Conference, March 19, 2025

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
OK